biopharmaceutics


Also found in: Dictionary, Encyclopedia.

bi·o·phar·ma·ceu·tics

(bī'ō-far'mă-sū'tiks),
The study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action, including coconstituents and mode of manufacture.

biopharmaceutics

(bī′ō-fär′mə-so͞o′tĭks)
n.
(used with a sing. verb) The study of the properties of pharmaceutical preparations and their effects after administration.

biopharmaceutics

[-fär′məso̅o̅′tiks]
the study of the chemical and physical properties of drugs, their components, and their activities in living organisms. See also pharmacokinetics and pharmacodynamics.

bi·o·phar·ma·ceu·tics

(bī'ō-fahr'mă-sū'tiks)
The study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action.

bi·o·phar·ma·ceu·tics

(bī'ō-fahr'mă-sū'tiks)
Study of the physical and chemical properties of a drug, and its dosage form, as related to the onset, duration, and intensity of drug action.
References in periodicals archive ?
The Biopharmaceutics Classification System, or BCS, is a regulatory pathway enabling waivers of some clinical testing for some drugs under specific circumstances.
Journal of Biopharmaceutics & Biotechnology" is targeted to professionals in pharmaceutical sciences, medicine, medicinal chemistry, biotechnology, bioinformatics, biochemical engineering and the biomedical sciences.
to Attend The 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Self-identifies as a Biopharmaceutics Classification System (BCS), Bioequivalence, and Bioavailability Testing Facility
In an outline format, the text summarizes material on therapeutics and other basic principles such as dosage forms, math, biopharmaceutics, kinetics, basic and parenteral compounding, and drugs for various conditions, and includes case studies and about 1,000 practice questions with annotated answers.
The open forum will provide current thinking on and better understanding of the regulatory application of the Biopharmaceutics Classification System (BCS) and the Biopharmaceutics and Drug Disposition Classification System (BDDCS) in biowaivers.
They select the most important physical chemistry in pharmaceutics and biopharmaceutics, without dealing with pharmacokinetics or many aspects of pharmaceutical production.
CONTACT: Kevin Stark of InCode BioPharmaceutics, Inc.
Fourteen papers, presented by Ghosh (Office of Clinical Pharmacology and Biopharmaceutics, Federal Department of Agriculture) and Pfister (Senior Director Preclinical Affairs, NexMed Inc.
Clinical aspects, including administration, potential hazards, and biopharmaceutics of sterile products in a clinical setting.
of Michigan) describe a range of current biotechnologies and methods developed in the fields of molecular biology, biochemistry, cell biology, immunology, recombinant protein biochemistry, biopharmaceutics, and related fields for the purpose of providing researchers with an introduction to the spectrum of methods and tools available in modern molecular and cellular biology research.